Nektar Therapeutics
SELECTIVE TREG STIMULATOR RUR20kD-IL-2 AND RELATED COMPOSITIONS
Last updated:
Abstract:
The instant disclosure provides selective Treg stimulator compositions, including RUR20kD-IL-2 and related compositions, and methods of using these compositions, for example, for treating autoimmune diseases, and/or other conditions responsive to therapy that is effective to provide a selective increase in numbers and activation of regulatory T cells over effector T cells.
Status:
Application
Type:
Utility
Filling date:
20 May 2019
Issue date:
8 Jul 2021